166 related articles for article (PubMed ID: 6604918)
1. Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor.
Zacharchuk CM; Drysdale BE; Mayer MM; Shin HS
Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6341-5. PubMed ID: 6604918
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of macrophage-mediated cytotoxicity: production of a soluble cytotoxic factor.
Drysdale BE; Zacharchuk CM; Shin HS
J Immunol; 1983 Nov; 131(5):2362-7. PubMed ID: 6415164
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide-mediated macrophage activation: the role of calcium in the generation of tumoricidal activity.
Drysdale BE; Yapundich RA; Shin ML; Shin HS
J Immunol; 1987 Feb; 138(3):951-6. PubMed ID: 3100622
[TBL] [Abstract][Full Text] [Related]
4. [Studies on characteristics of macrophage-derived cytotoxic factor].
Dong Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Oct; 12(5):375-9. PubMed ID: 2151695
[TBL] [Abstract][Full Text] [Related]
5. Correlation of macrophage-mediated tumor-cell lysis with the production of macrophage cytolytic factor (CF). Preliminary characterization of a factor inhibiting CF production.
Gifford GE; Loewenstein J; Yamin A; Gallily R
Int J Cancer; 1986 Jan; 37(1):73-9. PubMed ID: 3753597
[TBL] [Abstract][Full Text] [Related]
6. [Experimental analysis of cytotoxicity mediated by activated macrophages against glioma cells in mice].
Ohyama K
Nihon Geka Hokan; 1993 Mar; 62(2):92-115. PubMed ID: 8239865
[TBL] [Abstract][Full Text] [Related]
7. The human LT system. XI. Identification of LT and "TNF-like" forms from stimulated natural killers, specific and nonspecific cytotoxic human T cells in vitro.
Yamamoto RS; Ware CF; Granger GA
J Immunol; 1986 Sep; 137(6):1878-84. PubMed ID: 2943806
[TBL] [Abstract][Full Text] [Related]
8. Alteration of macrophage cytotoxicity through endogenous interferon and tumor necrosis factor alpha induction by propanil.
Theus SA; Tabor DR; Gandy J; Barnett JB
Toxicol Appl Pharmacol; 1993 Jan; 118(1):46-52. PubMed ID: 7679225
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages.
Urban JL; Shepard HM; Rothstein JL; Sugarman BJ; Schreiber H
Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5233-7. PubMed ID: 3487788
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
[TBL] [Abstract][Full Text] [Related]
11. A human macrophage hybridoma producing a cytotoxic factor distinct from TNF, LT, and IL-1.
Shimoda O; Takeda Y; Woo HJ; Shimada S; Higuchi M; Osawa T
Cancer Immunol Immunother; 1988; 26(2):101-8. PubMed ID: 3258790
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic lymphokines produced by cloned human cytotoxic T lymphocytes. II. A novel CTL-produced cytotoxin that is antigenically distinct from tumor necrosis factor and alpha-lymphotoxin.
Green LM; Reade JL; Ware CF; Devlin PE; Liang CM; Devlin JJ
J Immunol; 1986 Dec; 137(11):3488-93. PubMed ID: 2431035
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
[TBL] [Abstract][Full Text] [Related]
14. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
[TBL] [Abstract][Full Text] [Related]
15. Lymphotoxin amplification of tumor growth inhibition is specific for natural killer cells but not for macrophages.
Ransom JH; Pintus C; Evans CH
Int J Cancer; 1983 Jul; 32(1):93-7. PubMed ID: 6602781
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the macrophage hepatocytotoxicity and plasminogen activator activity of activated macrophages from guinea pigs by serum components from normal human and patients with liver diseases.
Mizoguchi Y; Tsutsui H; Monna T; Yamamoto S; Morisawa S
Jpn J Med; 1983 Apr; 22(2):112-6. PubMed ID: 6683338
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of nonspecific tumoricidal activity by activated macrophages with antiserum against a soluble cytotoxic factor.
Männel DN; Falk W; Meltzer MS
Infect Immun; 1981 Jul; 33(1):156-64. PubMed ID: 7021422
[TBL] [Abstract][Full Text] [Related]
18. Comparison of recombinant tumor necrosis factor and the monocyte-derived cytotoxic factor involved in monocyte-mediated cytotoxicity.
Nissen-Meyer J; Austgulen R; Espevik T
Cancer Res; 1987 May; 47(9):2251-8. PubMed ID: 3567918
[TBL] [Abstract][Full Text] [Related]
19. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
Jiang H; Stewart CA; Fast DJ; Leu RW
J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
[TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of action of guinea pig lymphotoxin. II. Increase of calcium uptake rate in LT-damaged target cells.
Okamoto M; Mayer MM
J Immunol; 1978 Jan; 120(1):279-85. PubMed ID: 304870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
